Early steroid withdrawal protocol using basiliximab in kidney transplantation.
Teraoka
S
S
Department of Surgery, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Sato
S
S
Kai
K
K
Kawase
T
T
Nakamura
M
M
Tojinbara
T
T
Nakajima
I
I
Fuchinoue
S
S
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000077552:Basiliximab; D002102:Cadaver; D003586:Cytomegalovirus Infections / Q000453:epidemiology; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000276:immunology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology*; D019520:Living Donors; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives*; D011183:Postoperative Complications / Q000453:epidemiology; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D014019:Tissue Donors
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D011993:Recombinant Fusion Proteins; D000077552:Basiliximab; D009173:Mycophenolic Acid; D008775:Methylprednisolone